Genomic variants in polycystic ovary syndrome

被引:43
作者
Luque-Ramírez, M
Millán, JLS
Escobar-Morreale, HF
机构
[1] Hosp Ramon & Cajal, Dept Endocrinol, E-28034 Madrid, Spain
[2] Hosp Univ Ramon & Cajal, Dept Mol Genet, Madrid, Spain
关键词
polycystic ovary syndrome; hyperandrogenism; insulin resistance; diabetes; obesity; inflammation; molecular genetics;
D O I
10.1016/j.cca.2005.10.017
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
The polycystic ovary syndrome (PCOS) is a common disorder in premenopausal women, characterized by the presence, among other traits, of hyperandrogenism, insulin resistance, and hyperinsulinism. The familial aggregation of PCOS lead the interest to the molecular genetic basis of this syndrome, especially to the genes encoding proteins involved in androgen synthesis and the regulation of insulin synthesis and action. Considering the relationship between insulin resistance and chronic inflammation, and the clustering of inflammatory markers in PCOS patients, recent studies focused on the involvement of proinflammatory genotypes on the pathogenesis of PCOS. Mounting evidence suggest at present a complex model of inheritance for PCOS, in which predisposing and protecting genomic variants interact with environmental factors such as obesity and a sedentary lifestyle, finally leading to the classic phenotype of this syndrome. Moreover, the association of hyperandrogenism, insulin resistance and chronic inflammation raised the possibility of an increase risk of cardiovascular disease in women suffering from PCOS. In the present review we will summarize the most important findings published to date regarding the molecular genetic mechanisms underlying the association of PCOS with insulin resistance and chronic inflammation, and the possible interaction of these mechanisms with environmental factors, (c) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:14 / 26
页数:13
相关论文
共 181 条
  • [21] Chen Zi-jiang, 2004, Zhonghua Fu Chan Ke Za Zhi, V39, P582
  • [22] Heritability of insulin secretion and insulin action in women with polycystic ovary syndrome and their first degree relatives
    Colilla, S
    Cox, NJ
    Ehrmann, DA
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (05) : 2027 - 2031
  • [23] THE TYROSINE KINASE DOMAIN OF THE INSULIN-RECEPTOR GENE IS NORMAL IN WOMEN WITH HYPERINSULINEMIA AND POLYCYSTIC-OVARY-SYNDROME
    CONWAY, GS
    AVEY, C
    RUMSBY, G
    [J]. HUMAN REPRODUCTION, 1994, 9 (09) : 1681 - 1683
  • [24] HEREDITARY FACTORS IN STEIN-LEVENTHAL SYNDROME
    COOPER, HE
    SPELLACY, WN
    PREM, KA
    COHEN, WD
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1968, 100 (03) : 371 - &
  • [25] Gene-environment interactions and the etiology of common complex disease
    Cooper, RS
    [J]. ANNALS OF INTERNAL MEDICINE, 2003, 139 (05) : 437 - 440
  • [26] Insulin resistance in the skeletal muscle of women with PCOS involves intrinsic and acquired defects in insulin signaling
    Corbould, A
    Kim, YB
    Youngren, JF
    Pender, C
    Kahn, BB
    Lee, A
    Dunaif, A
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2005, 288 (05): : E1047 - E1054
  • [27] Influence of SHBG gene pentanucleotide TAAAA repeat and D327N polymorphism on serum sex hormone-binding globulin concentration in hirsute women
    Cousin, P
    Calemard-Michel, L
    Lejeune, H
    Raverot, G
    Yessaad, N
    Emptoz-Bonneton, A
    Morel, Y
    Pugeat, M
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (02) : 917 - 924
  • [28] Fetal growth, length of gestation, and polycystic ovaries in adult life
    Cresswell, JL
    Barker, DJP
    Osmond, C
    Egger, P
    Phillips, DIW
    Fraser, RB
    [J]. LANCET, 1997, 350 (9085) : 1131 - 1135
  • [29] Overexpression of theca-cell messenger RNA in polycystic ovary syndrome does not correlate with polymorphisms in the cholesterol side-chain cleavage and 17α-hydroxylase/C17-20 lyase promoters
    Daneshmand, S
    Weitsman, SR
    Navab, A
    Jakimiuk, AJ
    Magoffin, DA
    [J]. FERTILITY AND STERILITY, 2002, 77 (02) : 274 - 280
  • [30] The prevalence of 4G5G polymorphism of plasminogen activator inhibitor-1 (PAI-1) gene in polycystic ovarian syndrome and its association with plasma PAI-1 levels
    Diamanti-Kandarakis, E
    Palioniko, G
    Alexandraki, K
    Bergiele, A
    Koutsouba, T
    Bartzis, M
    [J]. EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2004, 150 (06) : 793 - 798